different pathogens have been associated with the development of subsequent joint inflammation", but material from such joints has invariably proved to be sterile. As a result, the concept of 'reactive' arthritis has emerged. In the UK, the commonest cause of reactive arthritis appears to be sexually acquired urethral infection by Chlamydia traehomatiss although other microorganisms may also be involved. The mechanistic link between the precipitating infection and synovial inflammation remains the subject of speculation, but there is preliminary evidence that in sexually acquired reactive arthritis, chlamydial antigens are present in inflamed synovium'', Similar evidence of dissemination of bacterial antigens has been found in reactive arthritis associated with yersinioais-", Urethritis, however, occurs in many cases of reactive arthritis in which sexually transmitted infection has been excluded and is commonly present in patients in whom the arthritis has been triggered by gut infection. It is possible that, in such cases, an urethral pathogen has escaped detection. Alternatively, the urethritis may, like the synovitis, be truly 'reactive'. The case report by Maxwell suggests that the latter explanation is correct. The urachal remnant is closely related embryologically to the urethra and has a similar uroepithelium but in this particular case the urachal sinus had no patent connection with the urogenital tract. In the absence of any extraordinary sexual practices, direct infection of the urachus would seem unlikely and the urachal tissue would not be directly accessible to any urethral microorganisms. The urachal inflammation would, therefore, seem to arise as a 'reaction' to the same factors that caused the relapse of the reactive arthritis. Whether or not there was re-infection of the urethra in this episode is unclear.
It would be of great interest to examine the urachal specimen further by using immunohistochemical techniques to look for bacterial antigens. It may be that such antigenic material is an important factor in the pathogenesis of the synovitis, urethritis and inflammation of the urachus. R A HUGHES Yersinia specificimmune complexesin the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis 1987; 46:510-14 Back pain at Greenwich Sir, Blower's article (April 1988 JRSM, p 203) is beautifully written and researched. However, I believe, it is misleading on the subject of neurological loss in sciatica.
Department of Rheumatology
I agree with his point that a patient with a definite single root weakness has an organic complaint (a prolapsed disc), however highly strung they may be. He then says that such patients are excellent candidates for surgery, with the implication that they should be referred for surgery.
James Cyriax! noted that a huge majority of patients with a nerve root palsy did very well without surgery. My own experience bears this out and I have also found that those patients with the most obvious definite neurological signs lose their pain the soonest. (Those with a suggestion of nerve root damage which never progresses to the full-blown picture are more difficult to manage without an operation.) Most orthopaedic surgeons on this side of the Atlantic prefer to operate on discs only when there is no alternative. Thus, I think it is important to recognize that the vast majority of patients with a nerve root palsy (due to a prolapsed disc) will do very well with an operation, but even better without one. N A WATSON London Reference 1 Cyriax JH. Textbook oforthopaedic medicinevol1; London:
Bailliere Tindall, 1982 Hyperbaric oxygen in multiple sclerosis
Sir, Dr Bates reviewed the results of this controversial treatment (September 1986 JRSM, p 535) without waiting for the final results of his own study'. This has now provided further evidence that additional oxygen may benefit multiple sclerosis patients, although the authors of this study continue to deny that it will be of value in the management of the disease. The preliminary communication from the Newcastle study2 reported improvements in 16 out of 60 patients in the oxygen group, compared to 4 out of 57 in the controls (P< 0.01), with 12 of these patients reporting improved bladder and bowel function, compared to 3 of the controls (P< 0.03).Clearly disappointed by their failure to reproduce the highly significant results of Fischer et aP, and without waiting for their trial to be completed, they concluded that, 'hyperbaric oxygen is unlikely to have a role in the management of a patient with multiple sclerosis.' However, their final results! show that the benefit in bladder bowel function in the oxygen group, assessed on the Kurtzke scale, was actually sustained for 6 months without additional treatment. This confirms improvement shown in 4 other double-blind studies 3 -e, two with objective evidence from detailed cystometric measurements 5 • e. It must be remembered that all of the trials to date have used chronically disabled patients. Dr Bates obviously must accept that bladder function is important in the management of multiple sclerosis and he has already admitted that any treatment found to be of value should be used in patients with less advanced disease", Multiple sclerosis patients with early bladder and bowel dysfunction must now be offered hyperbaric oxygen therapy.
The final report by Barnes et al. 1 also records a significant reduction in the rate of cerebellar deterioration in the oxygen group compared to the controls at one year (P<0.05). They state that, 'if this finding can be confirmed, then it may be of benefit to patients as there is no consistently successful treatment for cerebellar dysfunction.'
